Michael Lee Blum Homology Medicines, Inc. (FIXX) insider trading activity

FIXX Quotes by TradingView

Michael Lee Blum is Chief Commercial Officer of Homology Medicines, Inc.. Currently has a direct ownership of 13,538 shares of FIXX, which is worth approximately $0. The most recent transaction as insider was on Jan 09, 2023, when has been sold 2,454 shares (Common Stock) at a price of $1.39 per share, resulting in proceeds of $3,411. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.5K
0% 3M change
0% 12M change
Total Value Held $0

Michael Lee Blum Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 09 2023
SELL
Open market or private sale
$3,411 $1.39 p/Share
2,454 Reduced 15.35%
13,538 Common Stock
Jan 01 2023
BUY
Exercise of conversion of derivative security
-
7,590 Added 32.19%
15,992 Common Stock
MLB

Michael Lee Blum

Chief Commercial Officer
Bedford, MA

Track Institutional and Insider Activities on FIXX

Follow Homology Medicines, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FIXX shares.

Notify only if

Insider Trading

Get notified when an Homology Medicines, Inc. insider buys or sells FIXX shares.

Notify only if

News

Receive news related to Homology Medicines, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FIXX